Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
274.06+2.06 (+0.76%)
At close: 4:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/28/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3464.00
52 Week Low 380.55
50-Day Moving Average 3277.17
200-Day Moving Average 3231.74

Share Statistics

Avg Vol (3 month) 33.26M
Avg Vol (10 day) 34.07M
Shares Outstanding 5241.52M
Implied Shares Outstanding 6N/A
Float 877.48M
% Held by Insiders 11.18%
% Held by Institutions 116.70%
Shares Short (Jul 29, 2021) 41.56M
Short Ratio (Jul 29, 2021) 40.48
Short % of Float (Jul 29, 2021) 4N/A
Short % of Shares Outstanding (Jul 29, 2021) 40.64%
Shares Short (prior month Jun 29, 2021) 42.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 52.41%
Operating Margin (ttm)71.20%

Management Effectiveness

Return on Assets (ttm)68.31%
Return on Equity (ttm)133.85%

Income Statement

Revenue (ttm)7.77B
Revenue Per Share (ttm)31.98
Quarterly Revenue Growth (yoy)12,630.20%
Gross Profit (ttm)-222.04M
EBITDA 5.58B
Net Income Avi to Common (ttm)4.07B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)914.9M
Total Cash Per Share (mrq)3.75
Total Debt (mrq)256.8M
Total Debt/Equity (mrq)4.68
Current Ratio (mrq)2.67
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-354.87M
Levered Free Cash Flow (ttm)-1.08B
Advertisement
Advertisement